Recent research published in Periodontology 2000 suggests that maintaining good oral health through periodontal therapy and managing gum disease may reduce systemic inflammation and slow cognitive decline, making it an important strategy for healthy aging and preventing neurodegenerative diseases like dementia.
- Periodontal therapy and peri-implant management may reduce systemic inflammation linked to cognitive decline and dementia risk.
- Oral dysbiosis and gum disease are increasingly associated with neurodegenerative diseases through inflammatory pathways and microbiota imbalances.
- Untreated periodontitis promotes chronic low-grade inflammation that predisposes patients to systemic diseases, including calcific aortic valve stenosis and neurodegenerative disorders.
- Effective management of periodontal and peri-implant health may offer novel strategies for promoting healthy aging and preventing cognitive decline in older populations.
Periodontal therapy and peri-implant management may cut systemic inflammation and restore oral function and may be linked to slower cognitive decline, promoting healthy aging. The article was published on September 16 in Periodontology 2000.
Therefore, maintaining oral health may not only be a foundation of functional and nutritional well-being, but it may also be an adjustable strategy to support cognitive resilience in older populations, the authors wrote.
“As links between oral health and brain function become clearer, it is imperative to view periodontal and peri-implant health status not in isolation, but as integral components of systemic health with the potential to influence the trajectory of cognitive decline,” wrote the authors, led by Emilio Cafferata of Goethe University in Frankfurt, Germany.
Mounting evidence suggests that imbalances within a person’s microbiota and deregulation of the host immune response may play a major part in developing neurodegenerative diseases such as dementia.
To investigate the correlations among oral dysbiosis, including gum disease, and biological pathways that may add to the onset of neuroinflammation and neuropathology, a comprehensive narrative review of the latest experimental, clinical, and epidemiological insights was conducted.
Periodontitis is not only increasingly associated with bone and tooth loss but a range of systemic chronic noncommunicable diseases, like the life-threatening disease calcific aortic valve stenosis.
Continued deregulated chronic inflammation not only worsens gum tissue destruction, but it also promotes a low-grade inflammatory phenotype that may predispose patients to degenerative diseases such as neurodegenerative disorders, the authors wrote.
On the flip side, studies related to peri-implantitis remain comparatively limited and indirect. However, new data suggest possible systemic inflammatory and cognitive implications, they wrote.
In the future, researchers should conduct biomarker-driven, mechanism-oriented studies integrating systemic inflammatory mediators, neuroimaging parameters, and microbial profiling to better understand potential biological pathways and know which individuals would benefit most from dental interventions, they wrote.
“Effective management strategies targeting periodontal and peri-implant dysbiosis and restoring the immune imbalance may offer novel avenues for promoting healthy aging and preventing neuropathic morbidities,” Cafferata and colleagues wrote.
